Literature DB >> 33587240

Screening for SH3TC2 variants in Charcot-Marie-Tooth disease in a cohort of Chinese patients.

Bo Sun1,2, Zheng-Qing He1, Yan-Ran Li1, Jiong-Ming Bai1,3, Hao-Ran Wang1,3, Hong-Fen Wang1, Fang Cui1, Fei Yang1, Xu-Sheng Huang4.   

Abstract

Mutations in the SH3TC2 gene cause Charcot-Marie-Tooth disease type 4C (CMT4C), characterized by inherited demyelinating peripheral neuropathy. CMT4C is a common form of CMT4/autosomal recessive (AR) CMT1. This study examined the SH3TC2 variants, investigated genotype-phenotype correlations and explored the frequency of CMT4C in Chinese patients. A total of 206 unrelated patients of Chinese Han descent clinically diagnosed with CMT were recruited. All patients underwent detailed history-taking, neurological examination, laboratory workups, and electrophysiological studies. Genetic analysis was performed via high-throughput target sequencing (NGS). Three patients, one male and two females, were found to carry five SH3TC2 mutations: patient 1 (c.3154C > T, p.R1054X; c.929G > A, p.G310E); Patient 2 (c.2872_2872del, p.S958fs; c.3710C > T, p.A1237V) and Patient 3 (c.2782C > T, p.Q928X; c.929G > A, p.G310E). The c.2872_2872del, c.3710C > T and c.2782C > T variants were not reported before. CMT4C caused by SH3TC2 mutation is a very common type of CMT4/AR CMT1. Three novel mutations, c.2872_2872del, c.3710C > T and c.2782C > T, were found in this study. Combination of clinical phenotype, nerve conduction studies, genetic analysis and bioinformatics analysis are of vital importance in patients suspected as CMT.
© 2021. Belgian Neurological Society.

Entities:  

Keywords:  Charcot–Marie–Tooth disease type 4C; High-throughput target sequencing (NGS); SH3TC2 mutation

Mesh:

Substances:

Year:  2021        PMID: 33587240     DOI: 10.1007/s13760-021-01605-5

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.471


  23 in total

1.  Clinical and mutational spectrum of Japanese patients with recessive variants in SH3TC2.

Authors:  Jun-Hui Yuan; Akihiro Hashiguchi; Yuji Okamoto; Akiko Yoshimura; Masahiro Ando; Kazutaka Shiomi; Kayoko Saito; Makoto Takahashi; Keiko Ichinose; Takuma Ohmichi; Kazushi Ichikawa; Adachi Tadashi; Hiroshi Takigawa; Hidehiro Shibayama; Hiroshi Takashima
Journal:  J Hum Genet       Date:  2018-01-10       Impact factor: 3.172

2.  High frequency of SH3TC2 mutations in Czech HMSN I patients.

Authors:  P Laššuthová; R Mazanec; P Vondráček; D Sišková; J Haberlová; J Sabová; P Seeman
Journal:  Clin Genet       Date:  2011-03-01       Impact factor: 4.438

3.  Clinical and genetic spectra of Charcot-Marie-Tooth disease in Chinese Han patients.

Authors:  Bo Sun; Zhaohui Chen; Li Ling; Fei Yang; Xusheng Huang
Journal:  J Peripher Nerv Syst       Date:  2017-03       Impact factor: 3.494

4.  Charcot-Marie-Tooth disease.

Authors:  Kinga Szigeti; James R Lupski
Journal:  Eur J Hum Genet       Date:  2009-03-11       Impact factor: 4.246

Review 5.  Diagnosis and new treatments in genetic neuropathies.

Authors:  M M Reilly; M E Shy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-12       Impact factor: 10.154

6.  SH3TC2/KIAA1985 protein is required for proper myelination and the integrity of the node of Ranvier in the peripheral nervous system.

Authors:  Estelle Arnaud; Jennifer Zenker; Anne-Sophie de Preux Charles; Claudia Stendel; Andreas Roos; Jean-Jacques Médard; Nicolas Tricaud; Henning Kleine; Bernhard Luscher; Joachim Weis; Ueli Suter; Jan Senderek; Roman Chrast
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-29       Impact factor: 11.205

7.  Missense mutations in the SH3TC2 protein causing Charcot-Marie-Tooth disease type 4C affect its localization in the plasma membrane and endocytic pathway.

Authors:  Vincenzo Lupo; Máximo I Galindo; Dolores Martínez-Rubio; Teresa Sevilla; Juan J Vílchez; Francesc Palau; Carmen Espinós
Journal:  Hum Mol Genet       Date:  2009-09-10       Impact factor: 6.150

8.  Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center.

Authors:  Luca Gentile; Massimo Russo; Gian Maria Fabrizi; Federica Taioli; Moreno Ferrarini; Silvia Testi; Annalisa Alfonzo; M'Hammed Aguennouz; Antonio Toscano; Giuseppe Vita; Anna Mazzeo
Journal:  Neurol Sci       Date:  2020-01-04       Impact factor: 3.307

Review 9.  Charcot-marie-tooth disease and related neuropathies: molecular basis for distinction and diagnosis.

Authors:  D Pareyson
Journal:  Muscle Nerve       Date:  1999-11       Impact factor: 3.217

10.  Mutation Analysis of Gap Junction Protein Beta 1 and Genotype-Phenotype Correlation in X-linked Charcot-Marie-Tooth Disease in Chinese Patients.

Authors:  Bo Sun; Zhao-Hui Chen; Li Ling; Yi-Fan Li; Li-Zhi Liu; Fei Yang; Xu-Sheng Huang
Journal:  Chin Med J (Engl)       Date:  2016-05-05       Impact factor: 2.628

View more
  1 in total

1.  Pan-Cancer Analysis Reveals SH3TC2 as an Oncogene for Colorectal Cancer and Promotes Tumorigenesis via the MAPK Pathway.

Authors:  Chengzhi Huang; Hui Yi; Yue Zhou; Qing Zhang; Xueqing Yao
Journal:  Cancers (Basel)       Date:  2022-07-31       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.